USpolicy

News

PhRMA sues Trump administration over GLOBE rebate scheme

PhRMA is challenging the Trump administration's GLOBE model for Most-Favoured Nation pricing in Medicare Part B in a US district court.

News

New York declares measles outbreak a "disaster emergency"

The governor of New York has said rising cases of measles constitute a statewide disaster emergency, as cases in neighbouring Pennsylvania pass 1,000.

News

GLOBE model finalised, with narrowed scope and fewer savings

CMS has finalised a new drug pricing policy for Medicare that has drawn sharp criticism from the pharma industry.

News

PhRMA hires ex-House Majority Leader Eric Cantor as its CEO

Former Republican lawmaker Eric Cantor has been named as the new CEO of US pharma group PhRMA, replacing long-serving Stephen Ubl.

Market Access

Two business hands outstretched, one weighing cash, the other drugs, for balance

What the revised 340B rebate pilot programme means for pharm...

While the scope of the revised pilot is limited, it may be a harbinger for a broader policy shift.

Market Access

$100 notes in pill bottle on aquamarine background with spilled pills

How new PBM transparency rules will alter drug pricing

The complex drug pricing ecosystem means all stakeholders are scrambling to understand how the new regulations and PBMs’ adjustments will impact them.

PhRMA sues Trump administration over GLOBE rebate scheme

New York declares measles outbreak a "disaster emergency"

GLOBE model finalised, with narrowed scope and fewer savings

PhRMA hires ex-House Majority Leader Eric Cantor as its CEO

What the revised 340B rebate pilot programme means for pharm...

How new PBM transparency rules will alter drug pricing

argenx's Forte acquisition delivers coeliac trial win

Discover a new era of healthcare panel engagement: Grounded ...

USpolicy

Editor's Picks